The Motley Fool··Jonathan PoncianoMajor Investor Stakes $45M Position in Flat-Performing Novanta Stock
ACK Asset Management buys $44.6M stake in underperforming Novanta, betting on cyclical recovery in medical device and industrial automation markets.
NOVTNOVTUMTRNGVAWMSinstitutional investmentmedical technology